Tradewind BioScience logo

Tradewind BioScience

Tradewind BioScience is building tools to attack highly aggressive and deadly human cancers. Tradewind BioScience (Tradewind) is a biotech company that is building novel therapeutic antibodies to attack cancer stem cells, with an initial focus on ovarian cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://tradewindbio.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
38 Morningside Dr Daly City, CA, 94015-4509
Dr Daly City
United States
Email
Contact Number
+1 415-317-4818

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

Tradewind is developing a panel of antibody-based therapeutic candidates, both monovalent and bi-specific, targeting novel secreted proteins involved in maintaince of tumorigenesis.

In Jan 2018, Tradewind Biosciences received $120k in a seed round funding from Y Combinator.